Autonomix Medical (AMIX) Long-Term Deferred Tax (2025)

Autonomix Medical's (AMIX) quarterly Long-Term Deferred Tax came in at $23000.0 in Q3 2025, down 86.93% on a QoQ basis from $176000.0 in Q1 2025.

Autonomix Medical (AMIX) Long-Term Deferred Tax (2025) Analysis & Trends

Autonomix Medical (AMIX) has 1 years of Long-Term Deferred Tax data on file, last reported at $23000.0 in Q3 2025.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $23000.0 in Q3 2025; TTM through Sep 2025 was $23000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $176000.0, changed N/A from the prior year.
  • Long-Term Deferred Tax for Q3 2025 stood at $23000.0, down from $176000.0 in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for AMIX reached as high as $176000.0 in Q1 2025 and fell as low as $23000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Autonomix Medical 1.03 Mn 1.03 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 23,000.00
Mar 31, 2025 176,000.00